HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of alpha interferon levels by AZT treatment in HIV-seropositive patients.

Abstract
The effect of AZT on serum HIV p24 antigen and endogenous serum alpha interferon levels was studied in AIDS and ARC patients. Following administration of AZT there was a rapid decline in the serum levels of both HIV p24 antigen and alpha interferon. When AZT treatment was interrupted, the levels of both HIV p24 antigen and of interferon rapidly increased. These findings suggest that HIV or some other AZT sensitive microorganism is the inducer of interferon which is characteristically found in the serum of AIDS and symptomatic HIV infected patients. They also suggest that the rapid decline in interferon levels may underlie some of the symptomatic benefit that follows administration of AZT.
AuthorsE Buimovici-Klein, G F McKinley, M Lange, J A Sonnabend, V Mohan, M H Grieco, L Z Cooper
JournalJournal of experimental pathology (J Exp Pathol) Vol. 6 Issue 1-2 Pg. 31-9 ( 1992) ISSN: 0730-8485 [Print] United States
PMID1625038 (Publication Type: Journal Article)
Chemical References
  • HIV Antigens
  • Interferon-alpha
  • Zidovudine
Topics
  • HIV Antigens (blood, drug effects)
  • HIV Seropositivity (blood, drug therapy)
  • Humans
  • Interferon-alpha (blood)
  • Lymphocyte Activation (drug effects)
  • Zidovudine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: